Interleukin-1 receptor-associated kinase-3 is a key inhibitor of inflammation in obesity and metabolic syndrome.
<h4>Background</h4>Visceral obesity is associated with the rising incidence of type 2 diabetes and metabolic syndrome. Low-grade chronic inflammation and oxidative stress synergize in obesity and obesity-induced disorders.<h4>Objective</h4>We searched a cluster of molecules t...
Guardado en:
Autores principales: | Maarten Hulsmans, Benjamine Geeraert, Dieuwke De Keyzer, Ann Mertens, Matthias Lannoo, Bart Vanaudenaerde, Marc Hoylaerts, Nora Benhabilès, Christos Tsatsanis, Chantal Mathieu, Paul Holvoet |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7955218849234fcdac25ac8ae6965167 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
PPAR agonist-induced reduction of Mcp1 in atherosclerotic plaques of obese, insulin-resistant mice depends on adiponectin-induced Irak3 expression.
por: Maarten Hulsmans, et al.
Publicado: (2013) -
Decrease of miR-146b-5p in monocytes during obesity is associated with loss of the anti-inflammatory but not insulin signaling action of adiponectin.
por: Maarten Hulsmans, et al.
Publicado: (2012) -
CD36 inhibitors reduce postprandial hypertriglyceridemia and protect against diabetic dyslipidemia and atherosclerosis.
por: Alain Geloen, et al.
Publicado: (2012) -
Experimental modulation of Interleukin 1 shows its key role in chronic kidney disease progression and anemia
por: Inbar Bandach, et al.
Publicado: (2021) -
Traffic air pollution and oxidized LDL.
por: Lotte Jacobs, et al.
Publicado: (2011)